Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maione

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Minerva Chirurgica|May 1, 1994
[Late posttraumatic diaphragmatic hernia. A clinical case report]R De Blasio, P Maione, U Avallone, et al.
Current Medicinal Chemistry|February 23, 2005
Chemotherapy of breast cancer in the elderlyA Rossi, G Colantuoni, P Maione, et al.
Current Medicinal Chemistry|November 5, 2011
The role of antiangiogenetic agents in the treatment of breast cancerM A Bareschino, C Schettino, G Colantuoni, et al.
Current Medicinal Chemistry|September 15, 2009
Angiogenesis inhibitors and vascular disrupting agents in non-small cell lung cancerA Rossi, P Maione, M L Ferrara, et al.
Current Cancer Drug Targets|January 11, 2012
Targeting angiogenesis for treatment of NSCLC brain metastasesC Schettino, M A Bareschino, A Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Chemotherapy of advanced NSCLC in special patient populationC Gridelli, P Maione, A Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Treatment of advanced non-small cell lung cancerL De Petris, L Crinò, G V Scagliotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Italian clinical research in non-small-cell lung cancerC Gridelli, A Rossi, D Galetta, et al.
Current Medicinal Chemistry|June 6, 2012
The role of EGFR tyrosine kinase inhibitors in the first-line treatment of advanced non small cell lung cancer patients harboring EGFR mutationA Sgambato, F Casaluce, P Maione, et al.
Anticancer Research|March 26, 2002
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II studyC Gridelli, C Curcio, R V Iaffaioli, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Minerva Chirurgica|May 1, 1994
[Late posttraumatic diaphragmatic hernia. A clinical case report]R De Blasio, P Maione, U Avallone, et al.
Current Medicinal Chemistry|February 23, 2005
Chemotherapy of breast cancer in the elderlyA Rossi, G Colantuoni, P Maione, et al.
Current Medicinal Chemistry|November 5, 2011
The role of antiangiogenetic agents in the treatment of breast cancerM A Bareschino, C Schettino, G Colantuoni, et al.
Current Medicinal Chemistry|September 15, 2009
Angiogenesis inhibitors and vascular disrupting agents in non-small cell lung cancerA Rossi, P Maione, M L Ferrara, et al.
Current Cancer Drug Targets|January 11, 2012
Targeting angiogenesis for treatment of NSCLC brain metastasesC Schettino, M A Bareschino, A Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Chemotherapy of advanced NSCLC in special patient populationC Gridelli, P Maione, A Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Treatment of advanced non-small cell lung cancerL De Petris, L Crinò, G V Scagliotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Italian clinical research in non-small-cell lung cancerC Gridelli, A Rossi, D Galetta, et al.
Current Medicinal Chemistry|June 6, 2012
The role of EGFR tyrosine kinase inhibitors in the first-line treatment of advanced non small cell lung cancer patients harboring EGFR mutationA Sgambato, F Casaluce, P Maione, et al.
Anticancer Research|March 26, 2002
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II studyC Gridelli, C Curcio, R V Iaffaioli, et al.
Pageof 3